16-84170327-C-G
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_178452.6(DNAAF1):c.1499C>G(p.Pro500Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000143 in 1,611,858 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_178452.6 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 13Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAAF1 | NM_178452.6 | c.1499C>G | p.Pro500Arg | missense_variant | Exon 8 of 12 | ENST00000378553.10 | NP_848547.4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000637 AC: 97AN: 152180Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000181 AC: 45AN: 248722 AF XY: 0.0000962 show subpopulations
GnomAD4 exome AF: 0.0000911 AC: 133AN: 1459560Hom.: 1 Cov.: 94 AF XY: 0.0000702 AC XY: 51AN XY: 726174 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000637 AC: 97AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.000618 AC XY: 46AN XY: 74466 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:3
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
- -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Pro500Arg var iant in DNAAF1 has not been previously reported in individuals with pulmonary di sease, but has been identified in 0.25% (24/9432) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs1388 38276). Computational prediction tools and conservation analysis suggest that th e p.Pro500Arg variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while the clinical si gnificance of the p.Pro500Arg variant is uncertain, its frequency suggests that it is more likely to be benign. -
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at